Bixiye
Cholestasis Pruritus - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 4221 - 4226 ee natiijooyinka 4226
Bixiye
QP26-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026
Bixiye
QP25-26 MHCP Pharmacy Benefit Exclusion for Loargys
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026
Bixiye
QP24-26 Commercial Pharmacy Benefit Exclusion for Loargys
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026
Bixiye
QP23-26 Commercial and MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2026
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026
Bixiye
QP22-26 Preferred Drug List Update for Minnesota Health Care Programs (MHCP), Effective May 1, 2026
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 08, 2026